Learn About Adrenocortical Carcinoma

What is the definition of Adrenocortical Carcinoma?

Adrenocortical carcinoma (ACC) is a cancer of the adrenal glands. The adrenal glands are two triangle-shaped glands. One gland is located on top of each kidney.

What are the alternative names for Adrenocortical Carcinoma?

Tumor - adrenal; ACC - adrenal

What are the causes of Adrenocortical Carcinoma?

ACC is most common in children younger than 5 years old and adults in their 40s and 50s.

The condition may be linked to a cancer syndrome that is passed down through families (inherited). Both men and women can develop this tumor.

ACC can produce the hormones cortisol, aldosterone, estrogen, or testosterone, as well as other hormones. In women the tumor often releases these hormones, which can lead to male characteristics.

ACC is very rare. The cause is unknown.

What are the symptoms of Adrenocortical Carcinoma?

Symptoms of increased cortisol or other adrenal gland hormones may include:

  • Fatty, rounded hump high on the back just below the neck (buffalo hump)
  • Flushed, rounded face with pudgy cheeks (moon face)
  • Obesity
  • Stunted growth (short stature)
  • Virilization -- the appearance of male characteristics, including increased body hair (especially on the face), pubic hair, acne, deepening of the voice, and enlarged clitoris (females)

Symptoms of increased aldosterone are the same as symptoms of low potassium, and include:

  • Muscle cramps
  • Weakness
  • Pain in the abdomen
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Adrenocortical Carcinoma?

The primary treatment is surgery to remove the tumor. ACC may not improve with chemotherapy. Medicines may be given to reduce production of cortisol, which causes many of the symptoms.

Who are the top Adrenocortical Carcinoma Local Doctors?
Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Regents Of The University Of California

200 W Arbor Dr, 
San Diego, CA 
 (12.6 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Rana Mckay is a Hematologist Oncology specialist and a Hematologist in San Diego, California. Dr. Mckay and is rated as an Advanced provider by MediFind in the treatment of Adrenocortical Carcinoma. Her top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Mckay is currently accepting new patients.

Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Regents Of The University Of California

200 W Arbor Dr, 
San Diego, CA 
 (12.6 mi)
Experience:
12+ years
Languages Spoken:
English
Offers Telehealth

Tyler Stewart is a Hematologist Oncology specialist and a Hematologist in San Diego, California. Dr. Stewart has been practicing medicine for over 12 years and is rated as an Advanced provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Prostate Cancer, and Muscle Invasive Bladder Cancer.

 
 
 
 
Learn about our expert tiers
Learn More
Surgical Oncology | General Surgery
Surgical Oncology | General Surgery

Regents Of The University Of California

200 W Arbor Dr, 
San Diego, CA 
 (12.6 mi)
Languages Spoken:
English
Offers Telehealth

Jason Sicklick is a Surgical Oncologist and a General Surgeon in San Diego, California. Dr. Sicklick and is rated as a Distinguished provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Gastrointestinal Stromal Tumor, Adrenocortical Carcinoma, Adult Soft Tissue Sarcoma, Hernia Surgery, and Small Bowel Resection.

What is the outlook (prognosis) for Adrenocortical Carcinoma?

The outcome depends on how early the diagnosis is made and whether the tumor has spread (metastasized). Tumors that have spread usually lead to death within 1 to 3 years.

What are the possible complications of Adrenocortical Carcinoma?

The tumor can spread to the liver, bone, lung, or other areas.

When should I contact a medical professional for Adrenocortical Carcinoma?

Contact your provider if you or your child has symptoms of ACC, Cushing syndrome, or failure to grow.

What are the latest Adrenocortical Carcinoma Clinical Trials?
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Background: Neuroendocrine neoplasms (NENs) are rare cancers in the gastrointestinal tract, pancreas, lungs, adrenal glands, and other areas of the body. Many of these cancers have a high risk of relapse and a low chance of survival. Better treatments are needed.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase 1 Dose Escalation Study of Systemically Administered IL13Ra2 Chimeric Antigen Receptor (CAR) T Cells After a Nonmyeloablative Conditioning Regimen in Patients With Metastatic Melanoma and Other Solid Tumors

Summary: This phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of patients with stage IIIC or IV melanoma or solid tumors that have spread to other places in the body (metastatic). The study agent is called IL13Ralpha2 CAR T cells. T cells are a special type of white blood cell (immune cells) ...

Who are the sources who wrote this article ?

Published Date: August 21, 2024
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Habra M, Else T, Fassnacht M. Adrenocortical carcinoma. In: Robertson RP, ed. DeGroot's Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 98.

National Cancer Institute website. Adrenocortical carcinoma treatment (PDQ) - health professional version. www.cancer.gov/types/adrenocortical/hp/adrenocortical-treatment-pdq. Updated August 25, 2022. Accessed August 27, 2024.

Yeh MW, Livhits M, Duh Q-Y. The adrenal glands. In: Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, et al, eds. Sabiston Textbook of Surgery. 21st ed. St Louis, MO: Elsevier; 2022:chap 40.